Institute for Scintillation Materials, National Academy of Sciences of Ukraine, 60 Nauky Ave., Kharkiv 61001, Ukraine.
Institute for Scintillation Materials, National Academy of Sciences of Ukraine, 60 Nauky Ave., Kharkiv 61001, Ukraine.
Biochim Biophys Acta Biomembr. 2019 Jan;1861(1):123-129. doi: 10.1016/j.bbamem.2018.08.007. Epub 2018 Aug 15.
Individual and joint action of two water-soluble drugs, DMSO and tilorone, on model l-α-dipalmitoylphosphatidylcholine (DPPC) membranes were studied in equilibrium and kinetic regimes by differential scanning calorimetry (DSC). For equilibrium experiments, the drugs were introduced during preparation of the model membrane. In kinetic studies, one of the drugs was added to the DPPC membrane already containing the other drug, and the effects of drug-membrane interactions were monitored in real-time regime. It was found that tilorone and DMSO had opposite effects on the membrane melting temperature, which were non-additive under joint introduction of these drugs. Analysis of kinetics of DSC profiles under drugs introduction allowed us to discriminate two processes in drug-membrane interactions with different characteristic times, i.e., drug sorption onto the membrane (minutes) and drug diffusion through stacks of lipid bilayers (hours). It was established that 0.1 mol% DMSO effectively enhanced membrane penetration for tilorone with the rate of tilorone diffusion being dependent upon the scheme of drugs administration. A model was proposed describing how sorption of a dopant onto lipid membrane could affect the membrane permeability for other dopants. Conditions were determined for enhancement of membrane permeability, as it was observed for DPPC/DMSO/tilorone system.
采用差示扫描量热法(DSC)在平衡和动力学状态下研究了两种水溶性药物,DMSO 和替洛隆对模型 l-α-二棕榈酰磷脂酰胆碱(DPPC)膜的单独和共同作用。对于平衡实验,在制备模型膜的过程中引入药物。在动力学研究中,将一种药物加入到已经含有另一种药物的 DPPC 膜中,并实时监测药物-膜相互作用的影响。结果发现,替洛隆和 DMSO 对膜熔融温度有相反的影响,当这两种药物联合引入时,其影响是非加性的。对药物引入下 DSC 图谱动力学的分析,允许我们区分药物-膜相互作用中具有不同特征时间的两个过程,即药物吸附到膜上(分钟)和药物通过脂质双层堆栈扩散(小时)。结果表明,0.1mol% DMSO 可有效增强替洛隆对膜的穿透性,而替洛隆的扩散速率取决于药物给药方案。提出了一个模型,描述了掺杂剂吸附到脂质膜上如何影响其他掺杂剂的膜透过性。确定了增强膜透过性的条件,如在 DPPC/DMSO/替洛隆体系中观察到的那样。